Biotechnology Instruments Market Size, Share & Trends Analysis Report By Product (Analytical Instruments, Cell Culture Instruments, Cell Separation Instruments), By End-User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Biotechnology Instruments Market Size

The global biotechnology instruments market size was valued at USD 88.49 billion in 2025 and is projected to grow from USD 92.55 billion in 2026 to USD 132.53 billion by 2034, registering a CAGR of 4.59% during the forecast period from 2026 to 2034. North America dominated the biotechnology instruments market with a market share of 38.6% in 2025.

The growing use of precision medicine, increased knowledge of molecular biologics and genomics, and the rising need for spectroscopic techniques for drug development are some factors impacting the biotechnology instruments market share.

Biotechnology instruments are essential in biotechnological research, diagnosis, and production. This equipment is specifically engineered to examine, control, and handle biological samples and data.

The increased burden of chronic diseases and high demand for point-of-care (POC) tests/devices are contributing factors to the growth of the biotechnology instruments market. Furthermore, rising demand for biotechnology instruments and an aging population will likely drive market expansion. However, obstacles such as the high cost of biotechnology instruments and a scarcity of experienced personnel are projected to slow industry expansion.

Product Insights

The market is further segmented into Analytical Instruments (Polymerase Chain Reaction, Spectroscopy, Microscopy, Chromatography, Flow Cytometry, Sequencing, Microarray), Cell Culture Instruments (Culture Systems, Incubators, Cryostorage Equipment, Biosafety Equipment, Pipetting Instruments), Cell Separation Instruments (Centrifuge, Filtration Systems, Magnetic-activated Cell Separator Systems), Immunoassay Instruments, Clinical Chemistry Analyzers.

Analytical Instruments account for the largest share of the market. Analytical instruments are classified as Polymerase Chain Reaction (PCR), Spectroscopy, Microscopy, Chromatography, Flow Cytometry, Sequencing, and Microarray. Spectroscopy also measures the interaction between matter and electromagnetic radiation. In 2022, the analytical instruments segment held the greatest market share of 60%. This equipment, which includes technologies like mass spectrometry, chromatography, and spectroscopy, is critical in enabling precise analysis and characterization of biological samples, supporting applications ranging from drug development to genetic research. Their broad use emphasizes their importance in driving breakthroughs in the biotechnology industry, greatly contributing to research, development, and innovation.

The cell culture instruments segment is predicted to increase at the quickest CAGR over the forecast period. These devices, which include bioreactors, incubators, and culture media, aid in the growth and manipulation of cells for various purposes, including drug research, tissue engineering, and regenerative medicine. The expanding importance of cell-based therapeutics and the increasing need for customized medicine is driving the expansion of this sector, making cell culture tools a vital driver of innovation and progress in the biotechnology industry.

Request Customizationto receive a tailored report.

End-User Insights

Pharma and biotech companies influenced the market growth.Pharmaceutical and biotechnology firms use biotechnology equipment in this category for various objectives, including drug research, development, and production. In 2022, pharmaceutical and biotechnology businesses held a 40% market revenue share. These businesses rely heavily on various instruments, such as gene sequencers, protein analyzers, and high-throughput screening systems, to drive drug discovery, development, and production processes. The constant pursuit of breakthrough medicines, precision medicine, and sophisticated research methods fuels the need for cutting-edge biotechnology equipment, cementing their critical position in influencing the trajectory of scientific and medical advancements.

Biotechnology instruments are used in academic institutions and research institutes for various scientific activities, including fundamental research, advanced studies, and teaching. The academic and research institutes category will develop at the quickest CAGR during the projection period. Many biotechnology tools, including DNA synthesizers, flow cytometers, and microarray systems, are rapidly being used in academic and research institutes and laboratories. Increased multidisciplinary research, collaborations, and the pursuit of ground-breaking discoveries in domains such as genomics, proteomics, and synthetic biology are driving this expansion. The emphasis on innovation in research activities and the development of fundamental information puts academic and research institutions as major contributors to the dynamic growth of biotechnology instrument technologies.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global biotechnology instruments market shareholder and is estimated to grow at a CAGR of 8.8% over the forecast period. North America accounted for 45% of the global market due to the strong demand for and affordability of biotechnology instruments. Increased R&D activities and expanding public-private research investments boost demand, contributing to market growth. For example, the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response received nearly USD 1.4 billion in funding for Project NextGen in August 2023. This effort seeks to encourage the development of cutting-edge techniques and technologies that will give long-term protection against COVID-19. As a result, constant breakthroughs, increased government investments in biotechnology instruments, and inexpensive adoption of novel systems cement the United States as the world's most profitable market.

Furthermore, key product launches, a high concentration of market players or manufacturers' presence, acquisitions and partnerships among major players, and product launches by key players in the US are some of the other factors driving the growth of the market in the U.S. For example, in November 2021, Thermo Fisher Scientific introduced the Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR, a new IVD system. This system is intended to help with IVD testing and assay menu building. Such continual product launches are expected to propel the country's market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Biotechnology Instruments Market Trends

Asia-Pacific is anticipated to exhibit a CAGR of 9.1% over the forecast period. The rapid growth of biotechnology sectors in emerging economies such as China and India is primarily responsible for this trend. These countries' strong government support for biotechnology drives market expansion. Continuous R&D investments fuel demand for biotechnology instruments even more.

• For example, the Australian government announced a USD 400 million investment in March 2023 to assist medical research projects, including efforts to promote First Nation health. The Indian government announced the establishment of the Anusandhan National Research Foundation (ANRF) in August 2023, enabling the country's scientists to play a critical role in addressing global concerns. The government intends to allocate 500 billion (USD 6.05 billion) to the ANRF from 2023 to 2028. As a result, rising research expenditures and government investments are expected to drive market expansion in the Asia Pacific region.

The European market is likely to grow rapidly during the forecast period. The growing use of biotechnology-derived methodologies in the production of medicines, genetically modified crops, and advanced laser technologies for the treatment of malignancies and other neurological disorders is one of the key factors driving the growth of the biotechnology instruments market during the forecast period. Furthermore, growing government investment in biotechnology sector improvement and the presence of globally known health institutes are contributing to market progress in this region.

List of Key and Emerging Players in Biotechnology Instruments Market